Search Results - "VAKKALANKA, S"

Pectic oligosaccharide structure-function relationships: Prebiotics, inhibitors of Escherichia coli O157:H7 adhesion and reduction of Shiga toxin cytotoxicity in HT29 cells by Di, Rong, Vakkalanka, Malathi S., Onumpai, Chatchaya, Chau, Hoa K., White, Andre, Rastall, Robert A., Yam, Kit, Hotchkiss, Arland T.

“…•Determined bifidogenic citrus pectic oligosaccharide (POS) structural diversity.•Five citrus POS were anti-adhesive for Stx-producing E. coli…”
Get full text

332 Dual PI3K delta/gamma inhibition by RP6530 accentuates bortezomib activity in multiple myeloma cell lines by Viswanadha, S, Babu, G, Veeraraghavan, S, Vakkalanka, S

Get full text

388 Preclinical Characterization of RP7047, a Novel and Selective Inhibitor of Pyrimidine Synthesis for the Treatment of Acute Lymphoblastic Leukemia by Viswanadha, S, Prasanna, R, Merikapudi, G.S, Veeraraghavan, S, Vakkalanka, S

Get full text

Development of ZnsexTe1-x p-type contacts for high efficiency tandem structures by VAKKALANKA, S, FEREKIDES, C. S, MOREL, D. L

Get full text

II–VI compounds as the top absorbers in tandem solar cell structures by Mahawela, P., Sivaraman, G., Jeedigunta, S., Gaduputi, J., Ramalingam, M., Subramanian, S., Vakkalanka, S., Ferekides, C.S., Morel, D.L.

“…Efficiencies of 19% have been achieved with copper indium gallium diselenide (CIGS) solar cells with a band gap of about 1.1 eV. Simulations indicate that if…”
Get full text

1200 ORAL RP5237- a Novel, Selective, and Potent Inhibitor of PI3Kdelta With Therapeutic Potential in B-cell Lymphomas by Viswanadha, S, Prasanna, R, Muthuppalaniappan, M, Babu, G, Varanasi, K, Veeraraghavan, S, Vakkalanka, S

Get full text

Simultaneous quantitation of IC87114, roflumilast and its active metabolite roflumilast N-oxide in plasma by LC-MS/MS: application for a pharmacokinetic study by Thappali, Satheeshmanikandan RS, Varanasi, Kanthikiran VS, Veeraraghavan, Sridhar, Vakkalanka, Swaroop Kumar VS, K, Mukkanti

“…A sensitive and reliable high‐performance liquid chromatography–mass spectrometry (LC–MS/MS) was developed and validated for simultaneous quantification…”
Get full text

Transparent high-performance CDSE thin-film solar cells by Mahawela, P., Jeedigunta, S., Vakkalanka, S., Ferekides, C.S., Morel, D.L.

“…Simulations indicate that 25–30% efficiency can be achieved with a four-terminal thin-film tandem structure. The bottom low band gap cell can be CuIn 1− x Ga x…”
Get full text

Cranberry Xyloglucan Structure and Inhibition of Escherichia coli Adhesion to Epithelial Cells by Hotchkiss, Arland T, Nuñez, Alberto, Strahan, Gary D, Chau, Hoa K, White, André K, Marais, Jannie P. J, Hom, Kellie, Vakkalanka, Malathi S, Di, Rong, Yam, Kit L, Khoo, Christina

“…Cranberry juice has been recognized as a treatment for urinary tract infections on the basis of scientific reports of proanthocyanidin anti-adhesion activity…”
Get full text

RP12146, a novel, selective, and potent small molecule inhibitor of PARP 1/2, synergizes with SOC therapy in preclinical models of solid tumors by Viswanadha, S., Eleswarapu, S., Karnam, K., Vakkalanka, S.

Get full text

345 Preclinical profile of novel, potent, and selective PI3 kinase delta inhibitors by Viswanadha, S, Muthuppalaniappan, M.P, Varanasi, K.V.V.S, Babu, G, Lekkala, R.R, Veeraraghavan, S, Vakkalanka, S

Get full text

338 Preclinical profile of novel and potent c-Met kinase inhibitors by Vakkalanka, S, Muthuppalaniappan, M.P, Babu, G, Kuppireddi, S, Viswanadha, S, Veeraraghavan, S, Varanasi, K.K.V.S

Get full text

Effect of Pentoxifylline on the Pharmacokinetics of Rosiglitazone in Wistar Rats by VARANASI, K. K. V. S, POTHARAJU, S, RAJAK, S, VEERARAGHAVAN, S, MALLICK, P, VAKKALANKA, S. K. V. S

“…The aim of this study was to investigate the effect of pentoxifylline (PTX), an antiplatelet agent, on the pharmacokinetics of rosiglitazone (RSG) in rats…”
Get full text

Preclinical Profile of RP14042, a novel, selective, and potent small molecule inhibitor of PARP7 by Viswanadha, S., Eleswarapu, S., Karnam, K., Veeraraghavan, S., Kota, A., Vakkalanka, S.

Get full text

Simultaneous Determination of Methotrexate, Dasatinib and its Active Metabolite N- Deshydroxyethyl Dasatinib in Rat Plasma by LC-MS/MS: Method Validation and Application to Pharmacokinetic Study by Thappali, S.R. S., Varanasi, K.V. S., Veeraraghavan, S., Vakkalanka, S.K.V. S., Khagga, M.

“…Abstract Background: Dasatinib is a multi-kinase inhibitor that potently inhibits Bcr-Abl, Src family and platelet-derived growth factor receptor kinases…”
Get full text

Polymorphism of dextromethorphan oxidation in South Indian subjects by Mamidi, Rao N.V.S., Satyavageeswaran, Shreeram, Vakkalanka, Swaroopkumar V.S., Chaluvadi, Madhusudana R., Katneni, Kasiram, Brahmadevara, Nataraj, Damodarram, Govindadas, Subramaniam, Swaminathan

“…One hundred fifty‐six unrelated healthy South Indian subjects were phenotyped according to their ability to metabolize dextromethorphan to its O‐demethylated…”
Get full text

D101 INFLAMMATION IN THE TRANSPLANTED LUNG AND FIBROSIS: Rp6557, A Novel And Selective Pi3k [delta]/[gamma] Inhibitor, Reduces Expression Of Fibrotic Markers In Human Pulmonary Fibroblasts And Demonstrates Efficacy In A Rat Model Of Pulmonary Fibrosis by Routhu, K, Eleswarapu, S, Viswanadha, S, Vakkalanka, S

Get full text

Polymorphism of dextromethorphan oxidation in South Indian subjects by MAMIDI, R. N. V. S, SATYAVAGEESWARAN, S, VAKKALANKA, S. V. S, CHALUVADI, M. R, KATNENI, K, BRAHMADEVARA, N, DAMODARRAM, G, SUBRAMANIAM, S

“…One hundred fifty-six unrelated healthy South Indian subjects were phenotyped according to their ability to metabolize dextromethorphan to its O-demethylated…”
Get full text

C109 LUNG BIOLOGY: AT A CROSSROAD BETWEEN INJURY AND REPAIR: The Novel Pi3k[delta]/[gamma] Inhibitor, Rp6503, Differentially Modulates Mediator Release From Human Precision Cut Lung Slices (hpcls) And Human Airway Smooth Muscle (hasm) In Response To Tnf[alpha] And Ifn[gamma] Stimulation by Koziol-White, C, Zhao, H, Vakkalanka, S, Panettieri, R A

Get full text

Temperature- and pH-sensitive terpolymers for modulated delivery of streptokinase by Vakkalanka, S K, Brazel, C S, Peppas, N A

“…Controlled release devices were designed which respond to changes in pH and temperature by reversibly swelling and deswelling to control release of…”
Get more information